Unknown OBSERVATIONAL NCT05331547

BioFreedom™ BA9™ Ultra

A Pilot Study Registry of the BioFreedom™ BA9™ Ultra Drug-Coated Coronary Stent for Patients With ST Elevation Myocardial Infarct (STEMI) Undergoing Percutaneous Coronary Intervention (PCI)

Sponsor: Biosensors International

Conditions Cardiovascular Death Myocardial Infarction Revascularization

Interventions BioFreedom BA9 (SS) Ultra DCS

Updated 4 times since 2022 Last updated: Apr 11, 2022 Started: Jul 21, 2021 Primary completion: Jul 21, 2022 Completion: Jan 21, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Cardiovascular Death and Myocardial Infarction, this trial is ongoing. The trial is conducted by Biosensors International and has accumulated 4 data snapshots since 2021. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Feb 2024 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
May 2022 — Feb 2024 [monthly]

Recruiting

First recorded

Jul 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biosensors International
The University of Hong Kong

Data source: The University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hong Kong, Hong Kong